Carroll Financial Associates’s Immunogen Inc IMGN Stock Holding History

Carroll Financial Associates’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1K	Hold	221	–	–	﹤0.01%	1590
2021 Q3	$1K	Hold	221	–	–	﹤0.01%	1746
2021 Q2	$1K	Hold	221	–	–	﹤0.01%	1666
2021 Q1	$1K	Hold	221	–	–	﹤0.01%	1601
2020 Q4	$1K	Hold	221	–	–	﹤0.01%	1496
2020 Q3	$0	Hold	221	–	–	﹤0.01%	1731
2020 Q2	$1K	Hold	221	–	–	﹤0.01%	1480
2020 Q1	$0	Hold	221	–	–	﹤0.01%	1730
2019 Q4	$1K	Buy	221 +66	+43%	+$224	﹤0.01%	1494
2019 Q3	$0	Hold	155	–	–	﹤0.01%	1765
2019 Q2	$0	Hold	155	–	–	﹤0.01%	1753
2019 Q1	$0	Hold	155	–	–	﹤0.01%	1546
2018 Q4	$0	Sell	155 -53	-25%	-$322	﹤0.01%	1420
2018 Q3	$1K	Sell	208 -1	-0.5%	-$10	﹤0.01%	1288
2018 Q2	$2K	Hold	209	–	–	﹤0.01%	1181
2018 Q1	$2K	Hold	209	–	–	﹤0.01%	1168
2017 Q4	$1K	Hold	209	–	–	﹤0.01%	1210
2017 Q3	$1K	Hold	209	–	–	﹤0.01%	1175
2017 Q2	$1K	Hold	209	–	–	﹤0.01%	1164
2017 Q1	$0	Hold	209	–	–	﹤0.01%	1251
2016 Q4	$0	Hold	209	–	–	﹤0.01%	1234
2016 Q3	$0	Hold	209	–	–	﹤0.01%	1239
2016 Q2	$0	Hold	209	–	–	﹤0.01%	1240
2016 Q1	$1K	Hold	209	–	–	﹤0.01%	1096
2015 Q4	$2K	Buy	+209	New	+$2.57K	﹤0.01%	1014
2015 Q3	–	Sell	-237	Closed	-$3K	–	1184
2015 Q2	$3K	Buy	+237	New	+$2.6K	﹤0.01%	953
2014 Q3	–	Sell	-500	Closed	-$6K	–	962
2014 Q2	$6K	Hold	500	–	–	﹤0.01%	687
2014 Q1	$7K	Buy	+500	New	+$7.88K	﹤0.01%	609

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Carroll Financial Associates's IMGN Position: Q4 2021 in Review

Carroll Financial Associates held its Immunogen Inc (IMGN) position steady in Q4 2021 at 221 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1590.

Carroll Financial Associates first reported a position in IMGN in Q1 2014 and has held it in 28 quarters since. The position peaked at $7K in Q1 2014. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

Carroll Financial Associates held 221 shares of Immunogen Inc worth $1K as of Q4 2021.
Carroll Financial Associates left its Immunogen Inc share count unchanged in Q4 2021.
Immunogen Inc made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1590 holding.
Carroll Financial Associates first reported a position in Immunogen Inc in Q1 2014 and has held it in 28 quarters since.
Carroll Financial Associates's Immunogen Inc position peaked at $7K in Q1 2014.
236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.